Device typeGlutamic acid decarboxylase antibody (anti-GAD) IVD, kit, enzyme immunoassay (EIA): A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of antibodies to glutamic acid decarboxylase (anti-GAD) in a clinical specimen, using an enzyme immunoassay (EIA) method. It is typically used as a predictive marker for the progression of autoimmune diabetes and the eventual onset of insulin-dependent diabetes mellitus.
FDA categoryAutoantibodies, Glutamic Acid Decarboxylase (Gad)
Device ID04048474040876
Catalog numberEIA-4087
AvailabilityPrescription
Single useYes
MRI safetyLabeling does not contain MRI Safety Information